Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

News You Need to Know Today
Previewing TCT 2026 | CMS announces major TAVR updates | A breakthrough in tricuspid valve care | Transfemoral TMVR
Tuesday, September 15, 2026
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

Editor's Choice: Structural Heart Disease

Late-breaking clinical trials announced for TCT 2026 in San Diego

TCT 2026 will include a full schedule of late-breaking studies focused on minimally invasive interventions, pharmaceutics, structural heart disease and much more.

READ MORE >
TCT late breaking trial presentation in the main arena at TCT 2025. Photo by Michael Walter
Share on Twitter Share on Facebook Share on Linkedin

Late-breaking clinical trials announced for TCT 2026 in San Diego

Share on Twitter Share on Facebook Share on Linkedin
TCT late breaking trial presentation in the main arena at TCT 2025. Photo by Michael Walter
TCT 2026 will include a full schedule of late-breaking studies focused on minimally invasive interventions, pharmaceutics, structural heart disease and much more.
READ MORE >

CMS finalizes sweeping TAVR changes, including Medicare coverage for asymptomatic patients

After months of consideration, CMS has officially signed off on major changes to its TAVR policies. The treatment of asymptomatic patients is now covered by Medicare, for example, and fewer reporting requirements are in place when symptomatic patients undergo treatment.

READ MORE >
Heart cardiologists doctors surgery
Share on Twitter Share on Facebook Share on Linkedin

CMS finalizes sweeping TAVR changes, including Medicare coverage for asymptomatic patients

Share on Twitter Share on Facebook Share on Linkedin
Heart cardiologists doctors surgery
After months of consideration, CMS has officially signed off on major changes to its TAVR policies. The treatment of asymptomatic patients is now covered by Medicare, for example, and fewer reporting requirements are in place when symptomatic patients undergo treatment.
READ MORE >

Medical societies, aging advocates share early reactions to new TAVR policies

CMS just finalized significant changes to its TAVR coverage policies. Three leading cardiovascular health societies shared a joint statement summarizing their initial feedback. 

READ MORE >
Cardiologists employed by a hospital appear to be more likely to pursue cardiac catheterization or angioplasty than independent cardiologists. female physician male
Share on Twitter Share on Facebook Share on Linkedin

Medical societies, aging advocates share early reactions to new TAVR policies

Share on Twitter Share on Facebook Share on Linkedin
Cardiologists employed by a hospital appear to be more likely to pursue cardiac catheterization or angioplasty than independent cardiologists. female physician male
CMS just finalized significant changes to its TAVR coverage policies. Three leading cardiovascular health societies shared a joint statement summarizing their initial feedback. 
READ MORE >

Surgeon performs first implant of semi-rigid annuloplasty ring for tricuspid valve repair

The FDA-cleared device was built specifically with the tricuspid valve in mind. 

READ MORE >
Corcym TriMemo tricuspid semirigid cardiac surgical annuloplasty ring. The device gained FDA approval in April 2026, based on the safety data of the mitral version of the device used for nearly 20 years.
Share on Twitter Share on Facebook Share on Linkedin

Surgeon performs first implant of semi-rigid annuloplasty ring for tricuspid valve repair

Share on Twitter Share on Facebook Share on Linkedin
Corcym TriMemo tricuspid semirigid cardiac surgical annuloplasty ring. The device gained FDA approval in April 2026, based on the safety data of the mitral version of the device used for nearly 20 years.
The FDA-cleared device was built specifically with the tricuspid valve in mind. 
READ MORE >

WVU Heart and Vascular Institute, a known leader in cardiac surgery, celebrates a decade of success

The WVU Heart and Vascular Institute was founded in 2016 to help advance the diagnosis, management and treatment of cardiovascular disease. It is now nationally recognized for delivering high-quality care in addition to being a world leader in robotic cardiac surgery.

READ MORE >
West Virginia University (WVU) is celebrating a significant milestone: the 10-year anniversary of the WVU Heart and Vascular Institute.
Share on Twitter Share on Facebook Share on Linkedin

WVU Heart and Vascular Institute, a known leader in cardiac surgery, celebrates a decade of success

Share on Twitter Share on Facebook Share on Linkedin
West Virginia University (WVU) is celebrating a significant milestone: the 10-year anniversary of the WVU Heart and Vascular Institute.
The WVU Heart and Vascular Institute was founded in 2016 to help advance the diagnosis, management and treatment of cardiovascular disease. It is now nationally recognized for delivering high-quality care in addition to being a world leader in robotic cardiac surgery.
READ MORE >

‘This could be transformative’: Surgeon performs first US implant of heart valve still under FDA review

The size-adjustable pulmonary valve was originally developed by Autus Valve Technologies, which Edwards Lifesciences acquired for $128.9 million. The device was designed to grow with pediatric patients as they age. Clinicians can expand it as necessary with a minimally invasive balloon procedure. 

READ MORE >
Jennifer Romano, MD, MS, a surgeon with at C.S. Mott Children’s Hospital
Share on Twitter Share on Facebook Share on Linkedin

‘This could be transformative’: Surgeon performs first US implant of heart valve still under FDA review

Share on Twitter Share on Facebook Share on Linkedin
Jennifer Romano, MD, MS, a surgeon with at C.S. Mott Children’s Hospital
The size-adjustable pulmonary valve was originally developed by Autus Valve Technologies, which Edwards Lifesciences acquired for $128.9 million. The device was designed to grow with pediatric patients as they age. Clinicians can expand it as necessary with a minimally invasive balloon procedure. 
READ MORE >

FDA clears updates to new platform for cardiac imaging, visualization and navigation

The end-to-end platform provides ultrasound imaging courtesy of a 360° catheter that creates real-time 2D and 3D maps of the patient’s heart. It also offers advanced visualization and navigation capabilities.

READ MORE >
Luma Vision Verafeye
Share on Twitter Share on Facebook Share on Linkedin

FDA clears updates to new platform for cardiac imaging, visualization and navigation

Share on Twitter Share on Facebook Share on Linkedin
Luma Vision Verafeye
The end-to-end platform provides ultrasound imaging courtesy of a 360° catheter that creates real-time 2D and 3D maps of the patient’s heart. It also offers advanced visualization and navigation capabilities.
READ MORE >

Transfemoral TMVR linked to positive outcomes for high-risk heart patients, new data confirm

Researchers tracked several years of data from patients treated with one of nine different devices. They described the reduction in MR as “profound and durable.”

READ MORE >
The Sapien M3 system for transcatheter mitral valve replacement. Image courtesy of Edwards Lifesciences.
Share on Twitter Share on Facebook Share on Linkedin

Transfemoral TMVR linked to positive outcomes for high-risk heart patients, new data confirm

Share on Twitter Share on Facebook Share on Linkedin
The Sapien M3 system for transcatheter mitral valve replacement. Image courtesy of Edwards Lifesciences.
Researchers tracked several years of data from patients treated with one of nine different devices. They described the reduction in MR as “profound and durable.”
READ MORE >

Tricuspid valve repair linked to major benefits for high-risk heart patients

While T-TEER is already known to improve a patient's quality of life, this late-breaking study from ESC Congress 2026 confirmed it also improves survival and reduces the risk of heart failure hospitalization.

READ MORE >
An FDA panel will discuss its recommendations related to Abbott's TriClip G4 transcatheter edge-to-edge repair (TEER) system for tricuspid regurgitation.
Share on Twitter Share on Facebook Share on Linkedin

Tricuspid valve repair linked to major benefits for high-risk heart patients

Share on Twitter Share on Facebook Share on Linkedin
An FDA panel will discuss its recommendations related to Abbott's TriClip G4 transcatheter edge-to-edge repair (TEER) system for tricuspid regurgitation.
While T-TEER is already known to improve a patient's quality of life, this late-breaking study from ESC Congress 2026 confirmed it also improves survival and reduces the risk of heart failure hospitalization.
READ MORE >

No significant sex-based differences in timing of care for M-TEER patients

Previous studies over the years have suggested women with severe mitral regurgitation face longer delays in care than men. This latest analysis suggests multidisciplinary care teams are helping put an end to that trend.

READ MORE >
cardiologist viewing heart data
Share on Twitter Share on Facebook Share on Linkedin

No significant sex-based differences in timing of care for M-TEER patients

Share on Twitter Share on Facebook Share on Linkedin
cardiologist viewing heart data
Previous studies over the years have suggested women with severe mitral regurgitation face longer delays in care than men. This latest analysis suggests multidisciplinary care teams are helping put an end to that trend.
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

Medtech giant makes big move | The world’s top hospitals for heart surgery | New CPT codes | PET vs. SPECT | TAVR tech recalled
AI is gaining ground, but clinicians run the show | Siemens Healthineers doubles down | Electrophysiologist compensation
News Alert: FDA shares warning about heart valve tech after patient death
Cardiologist pay & productivity are up | FDA clears PE thrombectomy devices | Cardiology tech in spotlight | Gore's new approval
Cardiology salaries on the rise | The climbing costs of care | M&A trends | Siemens Healthineers, J&J make big business moves
Major MRI trends | Blood thinner recalled | When to perform PCI before TAVR | How to build a CCTA program | Steroids & the heart
CMS boosts coverage for heart failure tech | FDA approves CardioMEMS updates | LVADs linked to strokes, other risks
Newsletter archive
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
  • Press Releases
  • Submit Press Release
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
Design by Adaptive Theme
Trimed Popup